How Amazon Chime Could Steal Share from Microsoft’s Skype
Amazon is late to the UCaaS (Unified Communications as a Service) market. But Amazon Chime could still carve out a significant share of the market.
Point72 Asset Management opens new position in Pier 1 Imports
E-commerce represented approximately 1% of total sales in fiscal 2013, 4% in fiscal year 2014, 9% in the first quarter of fiscal 2015, and 9.7% in the second quarter of fiscal 2015.
Point72 Asset Management raises stake in Lumber Liquidators
The company “saw improvement in net sales trends over the course of the quarter as inventory levels recovered and the fall flooring season began.” But the shares are down 49% in the year to date.
Point72 Asset Management takes position in CymaBay Therapeutics
CymaBay Therapeutics is a clinical-stage biopharmaceutical company formerly known as Metabolex. It develops therapies to treat metabolic and rare diseases with high unmet need.
Point72 Asset Management adds position in Applied Genetic Tech
Using the company’s partnerships and experience in ophthalmology, it plans to expand into a disease indication with a larger market. The company says it expects to place a new product candidate for this large market opportunity into development some time in 2015.
What Does Zoom Offer Investors?
Zoom Video Communications (ZM) went public in April, and its shares soared more than 70% on its first day of trading.
Amazon Enters the Workplace Collaboration Space with Chime
Amazon (AMZN) recently threw its hat into the workplace collaboration services ring with the launch of Chime, the company’s version of Microsoft’s (MSFT) Skype for Business.
Point72 Asset Management lowers its position in Shutterfly
Shutterfly generates the majority of its revenues from professionally bound photo books, greeting cards, personalized calendars, and other photo-based merchandise.
Point72 Asset Management lowers position in Clearwater Paper
Clearwater Paper Corporation is a leading North American producer of private label tissue and paperboard products.
Point72 Asset Management adds to its position in Crocs Inc.
Veteran footwear and apparel industry executive Gregg Ribatt will join Crocs as CEO in late January 2015.
Point72 Asset Management increases its position in RCS Capital
In November, RCS Capital terminated a $700 million deal to acquire Cole Capital from ARCP. The companies announced the deal prior to ARCP’s disclosure of accounting errors.
Point72 Asset Management adds position in Catalyst Pharmaceutical
Catalyst Pharmaceutical is a development-stage biopharmaceutical company that develops therapies for rare neuromuscular and neurological diseases.